HRP20120147T1 - Titracija tapentadola - Google Patents
Titracija tapentadola Download PDFInfo
- Publication number
- HRP20120147T1 HRP20120147T1 HR20120147T HRP20120147T HRP20120147T1 HR P20120147 T1 HRP20120147 T1 HR P20120147T1 HR 20120147 T HR20120147 T HR 20120147T HR P20120147 T HRP20120147 T HR P20120147T HR P20120147 T1 HRP20120147 T1 HR P20120147T1
- Authority
- HR
- Croatia
- Prior art keywords
- dose
- tapentadol
- administration
- administration interval
- interval
- Prior art date
Links
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 title claims abstract 27
- 229960005126 tapentadol Drugs 0.000 title claims abstract 27
- 238000004448 titration Methods 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 9
- 229940079593 drug Drugs 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesive Tapes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07008218A EP1985292A1 (en) | 2007-04-23 | 2007-04-23 | Titration of tapentadol |
| PCT/EP2008/003178 WO2008128740A1 (en) | 2007-04-23 | 2008-04-21 | Titration of tapentadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120147T1 true HRP20120147T1 (hr) | 2012-03-31 |
Family
ID=38123877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20120147T HRP20120147T1 (hr) | 2007-04-23 | 2012-02-15 | Titracija tapentadola |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US20090012180A1 (es) |
| EP (5) | EP1985292A1 (es) |
| JP (4) | JP5933176B2 (es) |
| KR (3) | KR20100017267A (es) |
| CN (1) | CN101730530B (es) |
| AT (1) | ATE534378T1 (es) |
| AU (1) | AU2008241013B2 (es) |
| CA (1) | CA2683786C (es) |
| CY (1) | CY1112320T1 (es) |
| DK (1) | DK2148670T3 (es) |
| ES (1) | ES2378255T3 (es) |
| HK (1) | HK1140940A1 (es) |
| HR (1) | HRP20120147T1 (es) |
| IL (1) | IL201479A (es) |
| MX (1) | MX2009011444A (es) |
| NZ (1) | NZ580415A (es) |
| PL (1) | PL2148670T3 (es) |
| PT (1) | PT2148670E (es) |
| RU (1) | RU2472497C2 (es) |
| SI (1) | SI2148670T1 (es) |
| WO (1) | WO2008128740A1 (es) |
| ZA (1) | ZA200907355B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| PE20142368A1 (es) * | 2008-10-30 | 2015-02-04 | Gruenenthal Chemie | Formas de dosificacion del tapentadol novedosas y potentes |
| US8870876B2 (en) * | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US8277459B2 (en) * | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
| US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US20130116333A1 (en) * | 2010-05-05 | 2013-05-09 | Ratiopharm Gmbh | Solid tapentadol in non-crystalline form |
| US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| SI2588093T1 (sl) * | 2010-06-30 | 2016-10-28 | Gruenenthal Gmbh | Tapentadol za uporabo pri zdravljenju sindroma razdražljivega črevesja |
| PT3656765T (pt) * | 2010-07-23 | 2021-05-25 | Gruenenthal Gmbh | Sais ou cocristais de 3-(3-dimetilamino-1-etil-2- metilpropil)fenol |
| CN101948397A (zh) * | 2010-09-07 | 2011-01-19 | 天津泰普药品科技发展有限公司 | 镇痛药他喷他多重要中间体的制备方法 |
| RS54711B1 (en) * | 2011-03-04 | 2016-08-31 | Grünenthal GmbH | PARENTERAL TAPENTADOL ADMINISTRATION |
| KR102039320B1 (ko) | 2011-03-04 | 2019-11-01 | 그뤼넨탈 게엠베하 | 타펜타돌을 함유하는 반고체 수성 약제학적 조성물 |
| PT3287123T (pt) | 2011-03-04 | 2020-05-22 | Gruenenthal Gmbh | Formulação farmacêutica aquosa de tapentadol para administração oral |
| US20120309840A1 (en) * | 2011-04-05 | 2012-12-06 | Gruenenthal Gmbh | Treatment of Pain Associated with Trigeminal Neuralgia |
| DK2694049T3 (da) | 2011-04-05 | 2019-01-02 | Gruenenthal Gmbh | Tapentadol til forebyggelse af kronificering af smerte |
| US20120277319A1 (en) | 2011-04-29 | 2012-11-01 | Gruenenthal Gmbh | Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety |
| WO2014152296A1 (en) * | 2013-03-15 | 2014-09-25 | Mallinckrodt Llc | Abuse deterrent solid dosage form for immediate release with functional score |
| EP2845625A1 (en) * | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| PL3273953T3 (pl) | 2015-03-27 | 2019-07-31 | Grünenthal GmbH | Stabilny preparat do pozajelitowego podawania tapentadolu |
| WO2016190766A1 (en) * | 2015-05-26 | 2016-12-01 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Compositions for use in treating parkinson's disease and related disorders |
| JP7373904B2 (ja) * | 2016-02-29 | 2023-11-06 | パーク・セラピューティクス・インコーポレイテッド | セブラノパドールの滴定 |
| MX2019003257A (es) | 2016-09-23 | 2019-06-10 | Gruenenthal Gmbh | Formulacion estable para la administracion parenteral de tapentadol. |
| WO2021185804A1 (en) | 2020-03-16 | 2021-09-23 | Grünenthal GmbH | Scored tablet |
| CN117042738A (zh) * | 2021-03-17 | 2023-11-10 | 埃科特莱茵药品有限公司 | 药物剂量系统 |
| EP4333820A1 (en) * | 2021-05-07 | 2024-03-13 | Grünenthal GmbH | Tapentadol for treating neuropathic pain in covid-19 patients |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| JPS6327805A (ja) | 1986-07-21 | 1988-02-05 | Sumitomo Electric Ind Ltd | 光フアイバの接続用部材及びそれを用いた接続方法 |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6339105B1 (en) * | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| PT1572167E (pt) | 2002-12-13 | 2008-10-03 | Euro Celtique Sa | Regime posológico de buprenorfina papa analgesia |
| US7413749B2 (en) | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
| DE102007019417A1 (de) | 2007-04-23 | 2008-11-13 | Grünenthal GmbH | Tapentadol zur Schmerzbehandlung bei Arthrose |
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
-
2007
- 2007-04-23 EP EP07008218A patent/EP1985292A1/en not_active Withdrawn
-
2008
- 2008-04-21 NZ NZ580415A patent/NZ580415A/en unknown
- 2008-04-21 PT PT08749016T patent/PT2148670E/pt unknown
- 2008-04-21 PL PL08749016T patent/PL2148670T3/pl unknown
- 2008-04-21 ES ES08749016T patent/ES2378255T3/es active Active
- 2008-04-21 CN CN200880021172XA patent/CN101730530B/zh active Active
- 2008-04-21 EP EP11008908A patent/EP2422778A1/en not_active Withdrawn
- 2008-04-21 MX MX2009011444A patent/MX2009011444A/es active IP Right Grant
- 2008-04-21 CA CA2683786A patent/CA2683786C/en active Active
- 2008-04-21 WO PCT/EP2008/003178 patent/WO2008128740A1/en active Application Filing
- 2008-04-21 AU AU2008241013A patent/AU2008241013B2/en active Active
- 2008-04-21 DK DK08749016.5T patent/DK2148670T3/da active
- 2008-04-21 KR KR1020097024357A patent/KR20100017267A/ko active Application Filing
- 2008-04-21 EP EP08749016A patent/EP2148670B1/en not_active Revoked
- 2008-04-21 EP EP16192734.8A patent/EP3143993A1/en not_active Withdrawn
- 2008-04-21 AT AT08749016T patent/ATE534378T1/de active
- 2008-04-21 KR KR1020177037810A patent/KR102078999B1/ko active IP Right Grant
- 2008-04-21 RU RU2009142940/15A patent/RU2472497C2/ru active
- 2008-04-21 KR KR20157003922A patent/KR20150027840A/ko not_active Application Discontinuation
- 2008-04-21 EP EP19189638.0A patent/EP3603630A1/en not_active Withdrawn
- 2008-04-21 JP JP2010504517A patent/JP5933176B2/ja active Active
- 2008-04-21 US US12/106,695 patent/US20090012180A1/en not_active Abandoned
- 2008-04-21 SI SI200830540T patent/SI2148670T1/sl unknown
-
2009
- 2009-10-13 IL IL201479A patent/IL201479A/en active IP Right Grant
- 2009-10-20 ZA ZA200907355A patent/ZA200907355B/xx unknown
-
2010
- 2010-08-02 HK HK10107329.5A patent/HK1140940A1/xx not_active IP Right Cessation
-
2012
- 2012-02-06 CY CY20121100123T patent/CY1112320T1/el unknown
- 2012-02-15 HR HR20120147T patent/HRP20120147T1/hr unknown
-
2015
- 2015-11-18 US US14/945,289 patent/US20160074342A1/en not_active Abandoned
-
2016
- 2016-01-21 JP JP2016009738A patent/JP2016128468A/ja active Pending
- 2016-12-05 US US15/369,257 patent/US20170079938A1/en not_active Abandoned
-
2017
- 2017-09-28 JP JP2017187306A patent/JP2018030864A/ja active Pending
-
2019
- 2019-04-10 JP JP2019074538A patent/JP2019131598A/ja active Pending
- 2019-06-12 US US16/439,135 patent/US11344512B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120147T1 (hr) | Titracija tapentadola | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| Zahrowski | Bisphosphonate treatment: an orthodontic concern calling for a proactive approach | |
| HRP20230272T1 (hr) | Postupci za liječenje cistične fibroze | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
| MA32692B1 (fr) | Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin | |
| BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
| JP2009102342A5 (es) | ||
| MX2008010155A (es) | Composiciones virucidales que contienen metal y sus usos. | |
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| RU2010147287A (ru) | Комбинированная композиция | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| SI2501234T1 (en) | METHODS AND INGREDIENTS FOR TREATMENT OF SYMPTOMS RELATED TO POST-TRAUMATIC STRESS EMISSIONS WITH THE USE OF CYCLOBENZAPRINE | |
| JP2012533554A5 (es) | ||
| RU2487707C2 (ru) | Применение парацетамола и ибупрофена в лечении | |
| RU2007103306A (ru) | Композиции на основе ризедроната и способы их применения | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| JP2016505050A5 (es) | ||
| UA57733C2 (uk) | Спосіб профілактики відсроченого блювання та назальний аерозольний препарат метоклопраміду | |
| ES2507570T3 (es) | Terapia de combinación de Zn/trimetoprim | |
| HRP20211661T1 (hr) | Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti | |
| US20080045482A1 (en) | Compositions and methods for the treatment of viral infections | |
| UA112652C2 (uk) | Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції | |
| CN117243948A (zh) | 包含瑞香素的组合物在制备风湿性关节炎药物中的应用 |